Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study

By J. Sousa, Marco A. Costa, Alexandre Abizaid, A. Abizaid, Fausto Feres, Ibraim M. F. Pinto, A. Seixas, R. Staico, L. A. Mattos, A. Sousa and 4 more. Circulation, 2001

777 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Biomedical Engineering, Surgery

View Paper: https://www.semanticscholar.org/paper/098bf397fc7c6d52ebb9699aa2a7196468548874

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Hung Cao
2. Ammar B. Kouki
3. Patrick R. Hunziker
4. Achraf Ben Amar

In Surgery

1. Renu Virmani
2. F. Kolodgie
3. Erling Falk
4. J. Bentzon

Citations in the corpus

• Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. (2006, background): “e rug-eluting stents (DES) are more effective than bareetal stents (BMS) in reducing restenosis and related target essel revascularization (TVR) (1–6), mainly by limiting ntimal hyperplasia (7), with similar rates in death or onfatal myocardial infarction (MI).”
• Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? (2004, background): “Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent Should We Be Cautious?”
• Power Approaches for Implantable Medical Devices (2015, background): “Unreachable locations in vertebrates’ bodies challenging scientists such as the deep brain, intravascular regions, inside the heart or even a location inside a single cell have been assessed and investigated with miniaturized implantable systems [13–16].”